WILMINGTON, MA – Implant Sciences Corporation, leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, [last week] reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
“Implant Sciences continues to expand its market share in the Latin American aviation security space. We believe that the combination of our superior performance and value proposition is the impetus behind this success, which could also set the stage for follow-on orders from these customers,” stated Dr. Darryl Jones, Implant Sciences’ Global Vice President of Sales and Marketing. “We are seeing a significant increase in demand for our products since our recent checkpoint certifications from theUS Transportation Security Administration (TSA) and the European Civil Aviation Conference (ECAC).”
“Our QS-B220 is specifically designed to meet the needs of aviation-related applications, including passenger, baggage, and cargo screening. As the only non-radioactive ETD in the world to pass the latest testing protocols of both TSA and ECAC, the QS-B220 is becoming the ETD of choice for a larger number of purchasers in the aviation security market,” added Dr. Bill McGann, CEO of Implant Sciences.
About the QS-B220 Desktop Explosives and Drugs Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About the QS-H150 Handheld Explosives Trace Detector
The QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the GSN Homeland Security Award for “Best Explosives Detection Solution” two years in a row (2013 and 2014). All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.
(The above press release was provided by Implant Sciences.)
Wilmington Apple 